2 results
Approved WMOCompleted
The primary objective of the study is to assess the progression-free survival (PFS) of oralveliparib in combination with temozolomide (TMZ) or in combination with carboplatin and paclitaxel compared to placebo plus carboplatin and paclitaxel.The…
Approved WMOCompleted
The objective of this study is to evaluate the effect of veliparib on QTcF.